Citation: Pj. Mroczkowski et al., Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis, CLIN EXP RH, 17(6), 1999, pp. S66-S68
Authors:
Weinblatt, ME
Reda, D
Henderson, W
Giobbie-Hurder, A
Williams, D
Diani, A
Docsa, S
Citation: Me. Weinblatt et al., Sulfasalazine treatment for rheumatoid arthritis: A metaanalysis of 15 randomized trials, J RHEUMATOL, 26(10), 1999, pp. 2123-2130
Authors:
Weinblatt, ME
Kremer, JM
Bankhurst, AD
Bulpitt, KJ
Fleischmann, RM
Fox, RI
Jackson, CG
Lange, M
Burge, DJ
Citation: Me. Weinblatt et al., A trial of etanercept, a recombinant tumor necrosis factor receptor : Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate, N ENG J MED, 340(4), 1999, pp. 253-259
Authors:
Weinblatt, ME
Kremer, JM
Coblyn, JS
Maier, AL
Helfgott, SM
Morrell, M
Byrne, VM
Kaymakcian, MV
Strand, V
Citation: Me. Weinblatt et al., Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis, ARTH RHEUM, 42(7), 1999, pp. 1322-1328
Authors:
Moreland, LW
Schiff, MH
Baumgartner, SW
Tindall, EA
Fleischmann, RM
Bulpitt, KJ
Weaver, AL
Keystone, EC
Furst, DE
Mease, PJ
Ruderman, EM
Horwitz, DA
Arkfeld, DG
Garrison, L
Burge, DJ
Blosch, CM
Lange, MLM
McDonnell, ND
Weinblatt, ME
Citation: Lw. Moreland et al., Etanercept therapy in rheumatoid arthritis - A randomized, controlled trial, ANN INT MED, 130(6), 1999, pp. 478